Cancer ResearchNot All Zombie Cells Are Bad — Precision Senolytic Therapy Is the Future of Anti-Aging
Scientists are rewriting the rulebook on senescent cells — the so-called zombie cells long blamed for accelerating aging. A major new review published in Aging-US confirms that while some senescent cells drive inflammation, organ decline, and disease, others actively support wound healing, tissue repair, and even embryonic development. This means blanket approaches to eliminating all senescent cells could do more harm than good. Researchers are now pivoting toward precision senolytics — therapies designed to selectively destroy only the damaging senescent cell populations while preserving the beneficial ones. For anyone tracking longevity science or considering senolytic supplements or therapies, this finding fundamentally changes how we should think about cellular aging interventions.
